AN OVERVIEW OF RECOMBINANT VACCINE TECHNOLOGY, ADJUVANTS AND VACCINE DELIVERY METHODS
نویسندگان
چکیده
منابع مشابه
Current vaccine adjuvants: an overview of a diverse class.
Numerous compounds are under evaluation as immunological adjuvants for improvement of vaccine performance. This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclinical and clinical studies.
متن کاملMicelle-Based Adjuvants for Subunit Vaccine Delivery
In the development of subunit vaccines with purified or recombinant antigens for cancer and infectious diseases, the design of improved and safe adjuvants able to efficiently target the antigen presenting cells, such as dendritic cells, represents a crucial challenge. Nanoparticle-based antigen delivery systems have been identified as an innovative strategy to improve the efficacy of subunit va...
متن کاملNovel Vaccine Delivery Technology
Infections of the respiratory and GI tracts are among the most common diseases of piglets worldwide and cause substantial economic loss to swine producers. Effective immunity to these infections needs a specific response at the surface of the tract (Bozic et al., 2002). However vaccine formulation and delivery to these surfaces remains a major challenge. Recent evidence of this type of immune r...
متن کاملBiodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine
Polymeric nanoand microparticles have recently been shown to possess significant potential as drug delivery systems. In particular, the use of biodegradable polymeric nanoparticles with entrapped antigens such as proteins, peptides, or DNA represents an exciting approach for controlling the release of vaccine antigens and optimizing the desired immune response via selective targeting of the ant...
متن کاملEnabling Vaccine Delivery Platforms and Adjuvants for Malaria
Enabling vaccine delivery platforms and adjuvants with promising attributes for malaria vaccine development are reviewed within the framework of accessibility, efficacy, clinical status, cost, and cold-chain considerations. An emphasis is placed on commercially available platforms and adjuvants including virus-like particle, nanoparticle, microneedle, and mRNA vaccine delivery platforms as well...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Pharmacy and Pharmaceutical Sciences
سال: 2016
ISSN: 0975-1491
DOI: 10.22159/ijpps.2016v8i11.14311